abstract |
Compounds of formula (I) and pharmaceutically acceptable salts thereof having angiotensin converting enzyme (ACE) and neutral endopeptidase (NEP) inhibitory activity, which are potent cardiovascular agents. Further disclosed is a pharmaceutical composition comprising said compounds useful for the treatment of hypertension |